drugset / Trial / NCT01804777

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

NCT01804777

RandomizedCrossoverDouble-blindHealth-services research

Summary

The purpose of this study is to determine with the administration of amiloride, observe an enhanced natriuresis, reduction in blood pressure and weight compared to the administration of hydrochlorothiazide in Type 2 Diabetics.

Timeline

Start
2013-03
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiloride Small molecule 20 mg
Comparator Hydrochlorothiazide Unknown 25 mg